Crewe Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252 | Hold |
|
|||||
|
2025
Q1 | $222 | Hold |
|
|||||
|
2024
Q4 | $273 | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $96.5K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $12.6K | Hold |
|
|||||
|
2022
Q4 | $14.8K | Hold |
|
|||||
|
2022
Q3 | $13K | Hold |
|
|||||
|
2022
Q2 | $12K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1K | Buy |
|